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The circadian nature of mood and its dysfunction in
affective disorders is well recognized, but the under-
lying molecular mechanisms are still unclear. Here,
we show that the circadian nuclear receptor REV-
ERBa, which is associated with bipolar disorder,
impacts midbrain dopamine production and mood-
related behavior in mice. Genetic deletion of the
Rev-erba gene or pharmacological inhibition of
REV-ERBa activity in the ventral midbrain induced
mania-like behavior in association with a central hy-
perdopaminergic state. Also, REV-ERBa repressed
tyrosine hydroxylase (TH) gene transcription via
competition with nuclear receptor-related 1 protein
(NURR1), another nuclear receptor crucial for dopa-
minergic neuronal function, thereby driving circadian
TH expression through a target-dependent antago-
nistic mechanism. In conclusion, we identified a
molecular connection between the circadian timing
system and mood regulation, suggesting that REV-
ERBa could be targeting in the treatment of circadian
rhythm-related affective disorders.
INTRODUCTION
Most physiological and behavioral functions in mammals are
constrained by daily oscillations generated by an internal time-
keeping system composed of clock proteins with interacting
positive and negative feedback loops. This hierarchically orga-
nized circadian timing system, with a master clock in the hypo-
thalamic suprachiasmatic nucleus (SCN) and subsidiary clocks
in extra-SCN brain regions and peripheral organs, mediates pe-
riodicities in physiological and behavioral output by regulating858 Cell 157, 858–868, May 8, 2014 ª2014 Elsevier Inc.cell type-specific sets of clock-controlled genes (Takahashi
et al., 2008; Menet and Rosbash, 2011).
Disrupted circadian rhythm is a key feature of affective
disorders, including major depressive disorder (MDD), bipolar
disorder (BPD), and seasonal affective disorder, which frequently
involve dysfunctions of midbrain dopaminergic (DAergic) neu-
rons underlying the brain reward system (Wulff et al., 2010).
Recent animal studies show that defective expression of
clock genes leads to behavioral abnormalities similar to those
observed in human mood disorders. For example, mice with a
defective allele of the circadian locomotor output cycles kaput
(Clock) gene (ClockD19) display mania-like behavior, robust
cocaine sensitization, and increased midbrain DAergic activity
(McClung et al., 2005; Roybal et al., 2007). The knockdown of
ClockmRNAexpression in the ventral tegmental area (VTA) leads
to a BPD-like phenotype characterized by a reduction in anxiety-
like behavior but increased depression-like behavior (Mukherjee
et al., 2010). Mutations of other clock genes also produce
behavioral abnormalities. For example, mice deficient in brain
and muscle Arnt-like protein-1 (Bmal1) or Period 2 (Per2) genes
exhibit mania-like behavior, whereas mice lacking both Crypto-
chrome1and2genesshowaltered anxiety-likebehavior (Hampp
et al., 2008; Kondratova et al., 2010; De Bundel et al., 2013).
These findings suggest that molecular components of the circa-
dian timing system have critical roles in mood regulation.
Accumulating clinical evidence implies the involvement of the
circadian nuclear receptor REV-ERBa in mood regulation. REV-
ERBa, which is encoded by theNR1D1 gene, constitutes a stabi-
lizing feedback loop by repressing the transcription of Bmal1
mRNA, which encodes a core transcriptional activator of circa-
dianmolecules (Preitner et al., 2002). Genetic variations in human
NR1D1 loci are associated with BPD onset and responsiveness
to lithium (Kripke et al., 2009; Severino et al., 2009; Etain et al.,
2011). In this regard, it is noteworthy that lithium-sensitive
glycogen synthase kinase 3 (GSK3) phosphorylates and stabi-
lizes REV-ERBa, influencing its ability to repress the transcription
Figure 1. Altered Mood-Related Behavior in RKO Mice
(A) Depression-like behavior at the indicated times for WT and RKO mice
(p < 0.05 for TST, p < 0.01 for FST, ANOVA, n = 6–8; *p < 0.05 and **p < 0.01
versus WT at CT22-02, yp < 0.05 and yyp < 0.01 versus WT at CT08–12,
Newman-Keuls tests).
(B) Anxiety-like behavior (p < 0.01, ANOVA, n = 7).
(C) Locomotor habituation to novelty (left; p < 0.01 for time, genotype, and
interaction effects, RM-ANOVA, n = 7) and total distance traveled (right;
p < 0.01, ANOVA).
(D) Aggression against a castrated male intruder (p < 0.05, ANOVA, n = 12).
Fractions indicate number of mice that attacked the intruder/total number of
mice.
(E) Innate fear response (p < 0.05, ANOVA, n = 7–11).
Data was presented as mean ± SEM.of downstream targets (Yin et al., 2006). Furthermore, certain
alleles in NR1D1 and GSK3b loci have additive effects on lithium
responsiveness among BPD patients (McCarthy et al., 2011).
Therefore, the present study aims to elucidate whether REV-
ERBa impacts mood by linking the molecular circadian clock
with the mood-controlling central DAergic system.
RESULTS
Abnormal Mood-Related Phenotypes of REV-
ERBa-Deficient Mice
To explore whether REV-ERBa plays a role in mood regulation,
we characterized the emotional phenotypes of Rev-erba
knockout (RKO) mice. In the despair-based tail suspension test
(TST) and forced swim test (FST), wild-type (WT) mice exhibited
daily variation in depression-like behaviors (Figure 1A) withgreater durations of immobility at subjective dusk (circadian
time 08–12 hr [CT08–12]) than at subjective dawn (CT22–02).
By contrast, RKO mice exhibited no such variation in behavior
and less depression-like behavior at dusk. Anxiety phenotypes
also differed between RKO and WT mice. WT mice showed
more anxiety-like behavior in the elevated plus-maze (EPM) at
dusk, whereas RKO mice spent similar times in open arms at
dusk and dawn (Figure 1B).WTmice also showed faster locomo-
tor habituation to a novel environment (Figure 1C, left) and
traveled less distance at dusk than at dawn (Figure 1C, right),
whereas RKO mice did not exhibit time-of-day variation in loco-
motion. Furthermore, male RKO mice were more aggressive
than WT mice. Less than 20% of WT mice attacked a castrated
male intruder, whereas more than 50% of RKO mice frequently
attacked an intruder (Figure 1D). Daily variation in aggression
was not found for either WT or RKO mice. It is noteworthy that
reduced depression-like behavior, increased risk-taking and hy-
peractivity, and unusual aggression are considered mania-like
phenotypes in rodents (Cryan and Slattery, 2007). On the other
hand, innate fear response was more robust in RKO mice than
in WTmice, as RKOmice froze more upon exposure to synthetic
predator feces odor (trimethylthiazoline [TMT]; Figure 1E) at
dusk. These findings suggest that RKO mice exhibit emotional
instability, mimicking, at least in part, symptoms observed in
human BPD patients.
Tyrosine Hydroxylase Mediates Circadian Nature of
Mood-Related Behavior
Abnormal mood-related behaviors, particularly mania-like phe-
notypes, often involve midbrain DAergic system dysfunction
(Nieoullon, 2002; Wulff et al., 2010). Considering the tran-
scriptionally repressive activity of REV-ERBa, we examined
genome-wide gene expression profiles in ventral midbrain
(VMB) tissue, where DAergic neurons are enriched. Microarray
analysis identified a subset of differentially expressed mRNAs
between RKO and WT mice (Figure S1A). Notably, expression
levels of tyrosine hydroxylase (TH) mRNA, which encodes a
rate-limiting enzyme for DA biosynthesis, was higher in RKO
than in WT mice. Its time-of-day expression pattern in WT mice
was comparable to that of Bmal1 mRNA, which is the primary
target of REV-ERBa (Figure 2A, top). TH and Bmal1mRNA levels
were elevated at night, which differed from the circadian oscilla-
tions of Rev-erba and Per2 mRNA levels (Figure 2A, bottom).
Expression levels of Nurr1mRNA, a key transcriptional activator
of TH, other DA-related genes (Zetterstro¨m et al., 1997), and
other mRNA species related to DAergic functions, were less
affected by time of day or the loss of functional REV-ERBa (Fig-
ures S1B and S1C). Immunohistochemistry revealed that TH
protein expression exhibited similar circadian variations in the
substantia nigra (SN) and VTA of WT mice (Figure 2B). Quantita-
tive analysis based on fluorescence-activated cell sorting (FACS)
supported this finding, showing that the proportion of TH-immu-
noreactive cells relative to NeuN-positive neuronal populations
was higher at CT00 than at CT12 (Figures 2C and S2). Such daily
variations were absent in RKO mice due to abnormally high TH
expression in both the SN and VTA at dusk (Figure 2D). These
results suggest that REV-ERBa regulates TH expression by a
suppressive mechanism.Cell 157, 858–868, May 8, 2014 ª2014 Elsevier Inc. 859
Figure 2. Circadian Rhythm of Midbrain TH Expression in WT Mice
(A) Circadian mRNA expression in the VMB (n = 3).
(B) Rhythmic TH protein expression in the SN and VTA. Scale bar represents 50 mm.
(C) Proportion of TH-immunoreactive (TH-ir) cells in the VMB (**p < 0.01, Student’s t test, n = 8).
(D) TH protein levels in SN (p < 0.05, ANOVA, n = 4) and VTA (p < 0.05, n = 4) lysates (*p < 0.05 and **p < 0.01 versusWT at CT00, yp < 0.05 and yyp < 0.01 versusWT
at CT12).
(E) Representative images of SN and VTA showing endogenous TH and AAV-mediated hTH-Myc protein expression. Scale bar represents 50 mm.
(F–I) Effect of constitutive hTH-Myc expression in the VMB on depression-like behavior (F; **p < 0.01, Student’s t test, n = 8), anxiety-like behavior (G; *p < 0.05,
n = 7), innate fear (H; *p < 0.05, n = 7), and novelty-induced locomotion (I; n = 8–11) at CT08–12.
Data was presented as mean ± SEM. See also Figures S1 and S2.To test whether altered TH expression leads to changes in
mood-related behavior, we constitutively expressed C-termi-
nally Myc-tagged human TH (hTH-Myc) under the control of a
CMV promoter in the VTA via an adeno-associated viral (AAV)
vector system. Immunostaining of AAV-infected mouse brain
sections with anti-TH or anti-Myc tag antibody showed that
approximately one-third of TH-positive cells in the VTA coex-
pressed Myc-tagged TH (Figure 2E; 41.11% ± 5.14%, n = 6,
calculated from three to four randomly chosen sections per
mouse within ±0.5 mm of the injection site). As expected, trans-
fected cells were mainly found in the VTA and rarely in the SN.
We then carried out behavioral testing of hTH-Myc-expressing
and GFP-transfected control mice at CT08–12. Similar to RKO
mice, Myc-tagged hTH-expressing mice showed reduced860 Cell 157, 858–868, May 8, 2014 ª2014 Elsevier Inc.despair- (Figure 2F) and anxiety-like behavior (Figure 2G) and
more robust innate fear (Figure 2H). However, novelty-induced
locomotion was equivalent in hTH-expressing and control mice
(Figure 2I), presumably because TH-immunoreactive neurons
were predominantly colocalized with viral-expressed hTH in
the VTA rather than the SN, where DAergic neurons are more
heavily involved in motor function (Nieoullon, 2002). These find-
ings indicate that arrhythmic and increased TH expression has a
role in the mania-like phenotype of RKO mice.
Midbrain DAergic Activity in REV-ERBa-Deficient Mice
Next, we compared central DAergic activity between RKO and
WTmice.We examined spontaneousDA release from striatal tis-
sue, containing both the caudate putamen (CPu) and nucleus
Figure 3. Dopaminergic Hyperactivity in RKO Mice
(A) Spontaneous DA release from statically incubated striatal tissue (p < 0.05,
ANOVA, n = 9–10; *p < 0.05 versus WT at CT00, yp < 0.05 versus WT at CT12).
(B) Extracellular DA levels in the NAc of freely moving mice (p < 0.01, ANOVA,
n = 5; yp < 0.05 and yyp < 0.01 versus WT at same time of day).
(C) Average firing rates of VTA units under presence of vehicle (VEH, DMSO) or
SR8278 (p < 0.05, drug effect, RM-ANOVA, n = 150 cells from 3mice; yp < 0.05
versus VEH at same time of day).
(D and E) Effect of systemic HALO or AMPT administration on depression-like
behavior (D; p < 0.01, ANOVA, n = 6–10) and anxiety-like behavior (E; p < 0.01,
n = 6; *p < 0.05 versus WT at CT20–24 and RKO mice; yp < 0.05 and yyp < 0.01
versus VEH mice of same genotype at same time of day).
Data was presented as mean ± SEM. See also Figures S3, S4, and S5.accumbens (NAc), that was statically incubated ex vivo. WT
striatal cultures prepared at CT00 released more DA than those
at CT12, but this variation was absent in RKO tissue due to
elevated DA release at CT12 (Figure 3A). Along with similar pro-
files of striatal DA contents and increased metabolite levels (Fig-
ures S3A and S3B), these results indicate that RKO mice show
altered DA production. Also, in vivo microdialysis revealed that
extracellular levels of DA and its metabolites were augmented
in the NAc of freely moving RKO compared with WT mice (Fig-
ures 3B, S3C, and S3D). Consistent with increased extracellular
DA levels, REV-ERBa also had a profound influence on VMB
electrophysiological properties (Figures 3C and S4). Multi-elec-
trode array recordings of single units in the VTA revealed that
acute inhibition of REV-ERBa activity by intracerebroventricular
(i.c.v.) application of the potent REV-ERBa antagonist SR8278
(Kojetin et al., 2011) augmented overall firing rate in freely moving
mice compared with vehicle injection regardless of the time of
day (Figure 3C), likely due to an increased proportion of fast-
spiking neurons (Figure S4). This increase in DA biosynthesis
and secretion in the VMB indicates a hyperDAergic state in
RKO mice.
We next examined whether increased DAergic activity was
associated with altered mood-related behavior in RKO mice.
Systemic administration of the DA receptor antagonist haloper-
idol (HALO) or the TH inhibitor a-methyl-p-tyrosine (AMPT)
attenuated daily variations in mood-related behavior in WT
mice by increasing depression- and anxiety-like behavior,
particularly during late nighttime (CT20–24). More importantly,
behavioral abnormalities of the RKO mice observed at duskwere ameliorated to levels comparable to those observed in
WT mice after application of either inhibitor (Figures 3D and
3E). Both inhibitors also reduced locomotion in WT mice at night
and hyperactivity in RKO mice during the day (Figures S5A and
S5B) and completely inhibited aggression in WT and RKO mice
(data not shown). We cannot completely rule out the possibility
that altered motor activity influenced the behavioral responses
because these inhibitors increased freezing behaviors of WT
mice tested at dusk (Figure S5C). Taken together with hTH-
Myc expression (Figures 2E–2I), our findings suggest that certain
mechanism(s) responsible for hyperDAergic activity during rest
periods may underlie reduced depression- and anxiety-like
behavior in RKO mice.
Inhibition of REV-ERBa Activity in the VMB Produces
Mania-like Behavior
As most TH-immunoreactive DA neurons coexpressed canoni-
cal clock proteins such as REV-ERBa, BMAL1, and PER1 (Fig-
ure 4A), we asked whether REV-ERBa locally expressed in the
VMB controls TH expression and impacts mood regulation.
Local inhibition of REV-ERBa activity by microinfusion of
SR8278 into the VMB of WT mice increased TH and Bmal1
mRNA expression at CT12 to levels comparable to those in
RKO mice, but SR8278 failed to alter TH expression in RKO
mice (Figure 4B), raising the possibility that REV-ERBa in the
VMB directly modulates TH mRNA expression.
Microinfusion of SR8278 into the VMB but not a control region
(i.e., periventricular gray [PVG]) resulted in behavioral abnor-
malities comparable to those found in RKO mice. SR8278
decreased despair-like immobility in WT mice during the day
(CT08–12 or zeitgeber time 08–12 [ZT08–12]) to a level compara-
ble to that in RKO mice, whereas it barely affected despair-like
behavior during the active period (CT or ZT20–24, Figure 4C).
Also, SR8278-infused mice showed less anxiety-like behavior
at dusk (Figures 4D and S6), more innate fear (Figure 4E), and
more aggression (Figure 4F) than vehicle-injected or PVG-tar-
geted mice.
When exposed to novelty, SR8278-infused WT mice were
more hyperactive than RKO mice under constant darkness,
traveling two to three times longer distances than WT mice at
CT20–24 (Figure 4G), whereas total distance traveled was
equivalent between RKO and WT mice at dawn (Figure 1C).
In this regard, it is noteworthy that RKO mice show impaired ex-
ercise capacity due to reduced mitochondrial content and
oxidative functions of skeletal muscle (Woldt et al., 2013).
Because microinfusion of SR8278 into the VMB did not disrupt
the muscular action of REV-ERBa, it is therefore plausible that a
more robust locomotor response could be observed. SR8278-
infused mice also showed hyperactivity in response to novelty
during the dark period of the LD cycle, but mice were less
active during the light period even though testing occurred un-
der dim red lighting. Considering that SR8278-infused mice
traveled longer distances than control mice at ZT08–12 under
the same lighting conditions, it appears that exposure to light
prior to testing may temporarily inhibit locomotor activity. Taken
together, these results demonstrate that REV-ERBa activity
in the VMB plays a central role in controlling mood and TH
mRNA expression.Cell 157, 858–868, May 8, 2014 ª2014 Elsevier Inc. 861
Figure 4. Influence of VMB REV-ERBa on
TH Expression and Mood-Related Behavior
(A) Coexpression of canonical clock proteins with
TH in the SN and VTA. Scale bar represents 50 mm.
(B) Effect of local infusion of VEH (DMSO) or
SR8278 into the VMB on relative mRNA expres-
sion levels of TH and Bmal1 at CT12 (*p < 0.05 and
**p < 0.01 versus VEH-injected WT; yp < 0.05
versus SR8278-injected WT, n = 6–8).
(C–E) Depression-like behavior (C; p < 0.01 for DD
and LD, ANOVA, n = 6–8), anxiety-like behavior (D;
p < 0.01 for DD, p < 0.05 for LD, ANOVA, n = 7–8),
and innate fear response (E; p < 0.01 for DD and
LD, ANOVA, n = 6–8; VEH: DMSO in the VMB, SR-
V: SR8278 in the VMB, SR-P: SR8278 in the PVG;
*p < 0.05 and **p < 0.01 versus mice of same
administration group at CT/ZT20–24, yp < 0.05 and
yyp < 0.01 versus vehicle-injected mice at same
time of day.
(F) Aggression against a castrated intruder at CT/
ZT08–12 (*p < 0.05 versus VEH or SR-P mice).
Fractions indicate number of mice that attacked
the intruder/total number of mice.
(G) Novelty-induced locomotion (left; p < 0.01,
time and treatment effects for DD and LD,
RM-ANOVA, n = 8–12 for DD and n = 7–8 for LD)
and total distance traveled (p < 0.01 for DD and
LD, ANOVA; *p < 0.05 versus mice of same
administration group at CT/ZT20–24, yp < 0.05 and
yyp < 0.01 versus vehicle-injected mice at same
time of day).
Data was presented as mean ± SEM. See also
Figure S6.Antagonistic Crosstalk between REV-ERBa and NURR1
in the Regulation of TH Gene Transcription
Because local REV-ERBa activity in the VMB controls THmRNA
expression, we tested whether REV-ERBa directly regulates TH
gene transcription by acting on its promoter using an immortal-
ized DAergic cell line (CATH.a; Suri et al., 1993). Sequence
analysis suggests several putative REV-ERBs/retinoic acid re-
ceptor-related orphan nuclear receptor (ROR) response ele-
ments (RREs), as well as E-box elements, which are recognized
by the CLOCK:BMAL1 heterodimer in the rat TH promoter region
located within5 Kb upstream of the coding sequence. Some of
these are well conserved among rats, mice, and humans (Fig-
ure 5A). REV-ERBa repressed rat TH promoter-driven luciferase
reporter (rTH-LUC) activity, but RORa and the CLOCK:BMAL1
heterodimer had little effect (Figure 5B). Interestingly, putative
RREs in the TH promoter overlapped with previously identified
cis-elements recognized by the nuclear receptor NURR1
(NBRE: NGFI-B response element; Figure 5A), which is required
for proper development and function of DAergic neurons (Zetter-
stro¨m et al., 1997; Kim et al., 2003). REV-ERBa antagonized
NURR1-induced activation of the TH promoter, whereas the862 Cell 157, 858–868, May 8, 2014 ª2014 Elsevier Inc.Bmal1 promoter was barely affected
by NURR1 overexpression (Figure 5B).
Such antagonistic crosstalk between
REV-ERBa and NURR1 was also demon-
strated for mouse and human TH pro-moter-driven reporters (mTH-LUC and hTH-LUC, respectively),
indicating evolutionary conservation (Figure 5C).
Serially truncated TH promoters and the 2.4 Kb promoters with
site-specific deletions revealed that two putative RREs/NBREs
(designated as R/N1 and R/N2, respectively) in a region between
2.6 and 1.2 Kb of the TH promoter serve as the main cis-acting
sites of this crosstalk (Figures 6A, 6B, and S7). Modulation of
endogenous REV-ERBa activity by treatment with REV-ERBa
agonist GSK4112 (Meng et al., 2008) or antagonist SR8278
differentially influenced TH promoter activity in an R/N1- and
R/N2-dependent manner (Figure 6C). Consistently, chromatin
immunoprecipitation (ChIP) assays revealed that both REV-
ERBa and NURR1 directly bound to R/N1 and R/N2 but did
not recognize the proximal NBRE on the TH promoter or the
RRE element on the Bmal1 promoter, respectively (Figure 6D).
This led us to ask how these nuclear receptors cooperate at
their recognition sites on the TH promoter. We found that
an increasing amount of GFP-tagged REV-ERBa repressed
FLAG-conjugated NURR1-induced TH promoter activation in a
dose-dependent manner (Figure 6E). Accordingly, expression
of GFP-REV-ERBa and Flag-NURR1 at different molar ratios
Figure 5. Transcriptional Regulation of the TH Promoter by REV-
ERBa
(A) Schematic diagram of rat, mouse, and human TH promoters. Putative RRE/
NBREs (R/Ns) and E-boxes were predicted using GENOMATIX software
(http://www.genomatix.de). Locations of cis-elements were estimated from
the start codon (+1) of the TH coding sequence.
(B) Effect of indicated transactivator expression on TH, Per1, and Bmal1
promoter activity. rTH-LUC: 5.2 Kb rat TH promoter, mPer1-LUC: 6.8 Kb
mouse Per1 promoter, and mBmal1-LUC: 0.9 Kb mouse Bmal1 promoter-
driven luciferase reporters (n = 4). Luciferase activity was normalized by co-
transfected pRL-TK and presented as mean ± SEM of arbitrary units (A.U.);
mean values of empty vector-transfected cells were set to 1 (CLK: CLOCK,
BM: BMAL1, REV: REV-ERBa, ROR: RORa, and NUR: NURR1).
(C) Effect of REV-ERBa and/or NURR1 on mouse and human TH promoter
activity. mTH-LUC: 2.3 Kb mouse TH promoter and hTH-LUC: 2.6 Kb human
TH promoter-driven luciferase reporters (n = 4).
Data was presented as mean ± SEM.followed by quantitative ChIP assays demonstrated that these
nuclear receptors compete to recognize R/N1 and R/N2 ele-
ments (Figure 6F). We thus speculate that target-dependent
antagonistic crosstalk between the two nuclear receptors under-
lies circadian TH expression.
REV-ERBa-Dependent Regulation of Histone
Acetylation at the TH Promoter
We next examined whether REV-ERBa and NURR1 also
competitively bind to R/N1 and R/N2 elements in vivo. Binding
of REV-ERBa to both R/N1 and R/N2 elements in WT VMB
lysates was stronger at CT12 than at CT00, with the opposite
pattern observed for NURR1 (Figure 7A). Daily variation in
REV-ERBa binding appeared to be more robust in the proximal
R/N1 element, whereas NURR1 more efficiently bound to the
R/N2 site. At CT12, the binding of NURR1 to the R/N elements
was higher for RKO than for WT mice (Figure 7A), and NURR1-
R/N1 binding was moderately higher in RKO mice at CT12 than
in WT mice at CT00. These findings indicate that target-depen-
dent antagonistic crosstalk between these nuclear receptors
can occur through competitive binding to R/N elements in vivo.REV-ERBa represses target gene transcription by recruiting
histone deacetylase 3 (HDAC3) complexes to the promoter re-
gion (Yin and Lazar, 2005; Feng et al., 2011). Thus, we examined
HDAC3 recruitment to the TH promoter region and its subse-
quent histone acetylation state. HDAC3 recruitment to the R/
N1 site followed a circadian rhythm in the WT VMB, but this
rhythm was absent in the RKO VMB (Figure 7B). By contrast,
there was little daily variation in HDAC3 recruitment to the
more distal R/N2 site, suggesting that it is less efficiently occu-
pied by REV-ERBa than the R/N1 site in vivo, as also implicated
in Figure 7A. Acetylation at lysine 9 of histoneH3 (H3-K9) showed
a circadian rhythm at all three examined TH promoter regions
in a REV-ERBa-dependent manner (Figure 7C). The circadian
pattern of histone acetylation coincides well with the TH mRNA
expression profile but is opposite to those for occupations by
REV-ERBa or HDAC3. H3-K9 acetylation and HDAC3 recruit-
ment to the proximal promoter region (PROX) resulted in daily
oscillations comparable to those found in the R/N1-containing
region. Taken together, these results suggest that REV-ERBa
controls TH gene expression by recruiting HDAC3 complexes,
which negatively regulate permissive histone acetylation to sup-
press transcriptional activation of the TH gene promoter.
DISCUSSION
The present study addresses the long-standing issue of the
circadian nature of mood regulation, which is thought to be
dysfunctional in a variety of mood disorders. We demonstrated
that the circadian nuclear receptor REV-ERBa particularly ex-
pressed in the VMB plays a pivotal role in controlling DAergic
function andmood-related behavior, as genetic ablation or phar-
macological inhibition of REV-ERBa affected mood in mice. Un-
like canonical RRE-mediated cyclic gene expression regulated
by competitive actions of REV-ERBs and RORs, REV-ERBa
competed with NURR1, a DA neuron-enriched nuclear receptor,
to regulate cyclic TH gene transcription, thereby contributing to
the circadian rhythmicity of the DAergic system (Figure 7D).
Patients with affective disorders such as BPD and MDD
commonly suffer from disrupted sleep-wake cycles and dysre-
gulated diurnal mood variation (Wulff et al., 2010; McCarthy
and Welsh, 2012). Recent advances in chronobiological
research facilitate the functional dissection of molecular links be-
tween circadian timing and mood-controlling systems. Several
previous studies of mutant mice with defective circadian clock
genes suggest crosstalk between molecular components of
the circadian clock and DAergic signaling at various regulatory
steps such as DA biosynthesis, transmission, and turnover
(McClung et al., 2005; Hampp et al., 2008; Spencer et al.,
2012). As a result, several key DA-regulating genes are proposed
to be controlled by circadian clockwork. For example, THmRNA
expression is augmented in the VMB of ClockD19 mutant mice,
suggesting that TH is negatively regulated by CLOCK (McClung
et al., 2005). Rather than direct control by CLOCK:BMAL1 heter-
odimer, the present study along with a previous report (Lemos
et al., 2007) suggests an indirect mechanism, although a nonca-
nonical mechanism cannot be ruled out. DAergic neural activity
and associated TH expression are also involved in the mania-
like phenotype of ClockD19mice (McClung et al., 2005; AumannCell 157, 858–868, May 8, 2014 ª2014 Elsevier Inc. 863
Figure 6. Regulation of TH Promoter Activ-
ity by Antagonistic Actions of REV-ERBa
and NURR1
(A) Schematic representation of WT and site-
directed mutated 2.4-Kb rat TH promoters.
(B) Transcriptional activities of 2.4 Kb WT and
mutated (m1, m2, and m1/2) TH promoters by
NURR1 and/or REV-ERBa expression (n = 3–6).
Luciferase activities were normalized by co-
transfected pRL-TK; mean values of WT promoter
activities in empty vector-transfected cells were
set to 1.
(C) Effect of GSK4112 or SR8278 on TH promoter
activity (**p < 0.01 versus other treatment; n =
7–16). Data was presented as mean ± SEM.
(D) ChIP assays on GFP-REV-ERBa and FLAG-
NURR1-expressing CATH.a cell lysates. Immu-
noprecipitation was performed using anti-GFP
(REV), anti-Flag (NUR), or anti-Histone H3 (H3)
antibody. Pre-immune IgG was used as a nega-
tive control. Indicated cis-element-containing
fragments were amplified by PCR (NBRE: proximal NBREs in the TH promoter; RRE: proximal RRE in the Bmal1 promoters).
(E) Dose-dependent repressive effect of REV-ERBa on TH promoter activity. The REV-ERBa expression construct was transfected with empty or NURR1-
expressing plasmid at the indicated ratios (n = 4).
(F) ChIP assays followed by qPCR on CATH.a cell lysates transfected with GFP-REV-ERBa- and/or FLAG-NURR1-expressing constructs at the indicated ratios.
Relative binding was calculated as mean ± SEM % of maximal binding obtained from lysates expressing only one construct (n = 3).
See also Figure S7.et al., 2011). Considering that Rev-erba mRNA expression is
severely attenuated in ClockD19 mice (Triqueneaux et al.,
2004), REV-ERBa may mediate the circadian control of DA
biosynthesis through transcriptional regulation of TH gene
expression.
Despite emerging evidence of a link between molecular path-
ways controlling circadian rhythms and DAergic transmission,
important issues still remain. For instance, circadian rhythm
amplitude, rather than steady-state activity, is likely more impor-
tant for proper mood regulation. Recent observations that mood
stabilizers such as lithium and valproic acid increase the ampli-
tude of clock gene expression rhythms support this hypothesis
(Johansson et al., 2011; Li et al., 2012). Furthermore, fibroblasts
obtained from BPD patients tend to exhibit lower amplitudes
of clock gene expression rhythms (Yang et al., 2009). Another
important issue concerns additional neural substrates related
to the circadian nature of mood control. Despite our demonstra-
tion that REV-ERBa actions in the DAergic system profoundly
influence mood-related behaviors in mice, clinical studies sug-
gest the involvement of multiple neural circuits, such as the
limbic system and underlying molecular mediators, in human af-
fective disorders (Wulff et al., 2010; McCarthy and Welsh, 2012).
Therefore, molecular nodes linking the circadian timing and
mood-controlling systems in discrete brain regions should be
systematically evaluated in consideration of their dynamic and
networking properties.
Genetic ablation or acute inhibition of REV-ERBa as well as
ectopic TH expression increased innate fear of predator odor
at dusk, whereas they usually led to attenuated depressive/
anxious state and induced a hyperlocomotive response to nov-
elty. Interestingly, controversial findings based on optogenetic
manipulation of DAergic neural activity were recently reported;
(Tye et al. 2013) demonstrated that phasic activation of DA neu-864 Cell 157, 858–868, May 8, 2014 ª2014 Elsevier Inc.rons in the VTA relieves a depression-like phenotype evoked by
chronic stress. Conversely, Chaudhury et al. (2013) reported that
similar activation of DA neurons during a social-interaction test
promotes a depression-like phenotype in a VTA-NAc circuit-
dependent manner. These findings support the idea that a
stress-responsive systemmay be involved in circadian dysregu-
lation in affective disorders (McClung, 2013). Given that impaired
REV-ERBa activity in the VMB led to increased DAergic activity
by inducing DA production and neural hyperactivity, it is reason-
able to speculate that emotional instability may depend on
discrete target regions/circuits of the central DA system in com-
bination with differential contexts, such as the mode and extent
of stressful stimuli.
REV-ERBa and its ortholog REV-ERBb are believed to
compete with RORs in controlling RRE-mediated transcription
(Preitner et al., 2002). We demonstrated that REV-ERBa
can also antagonize NURR1-induced TH gene transcription by
modulating permissive histone modification in a target pro-
moter-dependent manner. Despite the presence of specialized
cis-element(s) for crosstalk, the proximal NBRE element(s), to
which NURR1 but not REV-ERBa can bind, may still play a func-
tional role in the transcriptional regulation of the TH gene. These
characteristics provide a plausible explanation for why elimina-
tion of R/N elements barely increased basal THpromoter activity,
unlike Bmal1 expression (Preitner et al., 2002; Ueda et al., 2002).
In contrast to the ubiquitously expressed REV-ERBa, NURR1 is
enriched in the central nervous system, especially in the basal
ganglia and limbic areas (Zetterstro¨m et al., 1997). Therefore,
direct competition between these nuclear receptors on specific
cis-elements in the distal TH promoter exemplifies a novel tis-
sue-specific type of regulation. In this regard, it should be noted
that PER2 coordinates various nuclear receptors, including
REV-ERBa, via protein-protein interactions, suggesting possible
Figure 7. Competitive Binding of REV-ERBa and NURR1 to the TH
Promoter and Daily Variations in Histone Acetylation Associated
with HDAC3 Recruitment
(A) REV-ERBa- or NURR1-bound TH promoter fragments in VMB lysates (*p <
0.05 and **p < 0.01 versusWT at CT00, yp < 0.05 versusWT at CT12, Student’s
t test, n = 4, N.S. versus pre-immune serum used as negative control).
(B) HDAC3-bound TH promoter fragments expressed as mean ± SEM % of
total inputs (*p < 0.05 versus WT, n = 3).
(C) Histone H3-K9 acetylation profiles expressed asmean ±SEM%of total H3
(*p < 0.05 versus WT, n = 3).
(D) Hypothetical model for rhythmic TH gene expression in DAergic neurons
and its relevance to circadian mood regulation.crosstalk between REV-ERBa and other nuclear receptors
(Schmutz et al., 2010). A recent attempt to identify genome-
wide cis-acting REV-ERBs targets in liver tissue showed that a
broad range of nuclear receptor-binding sites are recognized
by REV-ERBa in addition to its classical binding motif (Cho
et al., 2012). REV-ERBa may likely be a more versatile regulator
of nuclear receptor signaling andmediator of functional circadian
outputs than previously thought, particularly with regard to its
actions in cellular context- and target-dependent manners.
Because heme was identified as an endogenous ligand for
REV-ERBs (Raghuram et al., 2007; Yin et al., 2007), they have
been considered the most promising target of small molecules
to treat circadian rhythm-related metabolic, cardiovascular,and psychiatric disorders. Several synthetic REV-ERBa/b mod-
ulators have been evaluated to test this idea (Meng et al.,
2008; Kojetin et al., 2011; Solt et al., 2012). (Solt et al. 2012)
recently developed potent REV-ERBa/b agonists allowing in vivo
application. Peripheral REV-ERBs are believed to have impor-
tant roles in glucose and lipid metabolism, as revealed by
expression profiles of metabolic genes in the liver, skeletal mus-
cle, and adipose tissue (Le Martelot et al., 2009; Cho et al., 2012;
Solt et al., 2012). Based on these roles, researchers examined
the effects of REV-ERBs agonists in diet-induced obese mice
and proposed that REV-ERBs ligands have clinical applications
for the treatment of metabolic diseases and sleep disorders (Solt
et al., 2012).
In conclusion, the present study demonstrates that midbrain
REV-ERBa links the molecular circadian clock with DA bio-
synthesis and thereby impacts mood regulation. Our findings
suggest the potential of REV-ERBa as a therapeutic target for
affective disorders associated with circadian dysfunction.
EXPERIMENTAL PROCEDURES
Animals
Male RKO and WT mice (10–15 weeks of age) were maintained in a C57BL/6J
background. Mice were housed in temperature-controlled (22C–23C) quar-
ters under a 12 hr light-dark (LD) photoperiod (lights on at 8:00 a.m.). After
entrainment for >10 days under LD conditions, mice were kept in constant
darkness (DD) for 2 days starting at lights-off time. On the third day, mice
were sacrificed at indicated time points by cervical dislocation. All behavioral
tests under DD conditions were performed on the third or fourth day. All pro-
cedures were approved by the Institutional Animal Care and Use Committee
of Seoul National University.
Plasmids
Expression vectors were previously described (Chopin-Delannoy et al., 2003;
Kim et al., 2003; Son et al., 2008). The rat 5.2 Kb TH promoter and its serially-
deleted derivatives were also previously described (Kim et al., 2003). WT and
site-specifically mutated 2.4 Kb rat (2,451 to 9 from translation start site),
mouse (2,306 to 1), and human TH promoters (2,523 to +76) were pre-
pared by PCR as described in the Extended Experimental Procedures.
Drug Application
HALO (0.2 mg/kg; Sigma-Aldrich) or AMPT (100 mg/kg; Sigma-Aldrich) were
injected intraperitoneally (i.p.) 1–2 hr before the test. SR8278was administered
i.c.v. (64 mg/mouse) 6 hr before electrophysiological recordings. For behavioral
studies and gene expression analyses, SR8278 was directly microinfused into
the VMB (16 mg/mouse) or PVG 4 hr before experiments. Detailed procedures
are described in the Extended Experimental Procedures.
Behavioral Studies
All behavioral tests were carried out at the indicated time of day under dim red
light.
Depression-like Behavior
Despair-based TST and FST were performed as previously described (Roybal
et al., 2007; Hampp et al., 2008) with modifications. For the TST, mice were
individually suspended by the tail in a white box (36.5 3 30.5 3 30.5 cm) for
6 min. They were considered immobile when agitation and escape attempts
ceased. For the FST, mice were placed in a transparent beaker (10 cm diam-
eter) containing water (21C–25C) at a depth of 15 cm for 6 min. Immobility,
defined as the absence of volitional body or limb movement, was scored as
the percentage of time spent immobile during the last 4 min.
EPM
EPM testing was performed as previously described (Chung et al., 2005). The
maze consisted of two open (5 3 30 cm) and two enclosed (5 3 30 cm) arms
with 20 cm high walls. The apparatus was elevated 50 cm above the ground.Cell 157, 858–868, May 8, 2014 ª2014 Elsevier Inc. 865
Micewere individually placed in the center of the apparatus facing an open arm
and allowed to explore for 10 min. Frequency and duration of arm entries were
recorded. An entry was defined as the movement of all four paws into an arm.
The percentage of time spent in open arms was scored.
Novelty-Induced Locomotion
The locomotor habituation test was conducted as previously described (Son
et al., 2007) withmodifications. Mice were individually placed into a novel Plex-
iglas box (2173 2683 104 mm) with bedding for 2 hr. Behavior was recorded
by an overhead video camera connected to a computer with tracking software
(Ethovision 3.1, Noldus).
Innate Fear in Response to Predator Odor
Mice were placed in a chamber with a beaker containing 30 ml TMT
(PheroTech) as previously described (Lee et al., 2011). Freezing behavior
was measured for 10 min and scored as the percentage of time spent freezing
during the last 4 min.
Aggression
Aggression was measured as previously described (Chamero et al., 2007)
with modifications. Male mice were isolated for 1 week before testing, and a
castrated male BALB/c intruder (8–9 weeks of age) was placed in their home
cage for 5 min. Numbers of aggressive contact behaviors such as tail rattling,
biting, chasing, and cornering were counted.
RNA and Protein Analyses
Tissue was rapidly removed and frozen in liquid nitrogen. Total RNA was
isolated by the single-step acid guanidinium thiocyanate-phenol-chloroform
method. Samples for immunoblot analyses were prepared by homogenization
of tissue in SDS lysis buffer. Detailed protocols for RNA and protein analyses
are described in the Extended Experimental Procedures.
FACS Analysis
Flow cytometry for DAergic neuronal populations was performed as previously
described (Guez-Barber et al., 2012). VMB tissue was rapidly dissected on an
ice-chilled brain-matrix from 2mm thick brain sections (twomice per analysis),
minced in ice-cold Hybernate A solution (Invitrogen), dissociated by incubation
with Accutase (Millipore), and subjected to FACS analyses as described in the
Extended Experimental Procedures.
DA Measurement
Ex vivo superfusion andmeasurements of DA andmetabolites were performed
as previously described (Geldenhuys et al., 2009). For static incubation,
dissected and minced striatal tissue was equilibrated for 60 min, and effluent
samples were collected three times at 20 min intervals. To examine extracel-
lular levels of DA and its metabolites in vivo, microdialysis probes with 1 mm
membrane length (CMA Microdialysis) were inserted in the ventral striatum.
Probes were perfused with sterile artificial cerebrospinal fluid at a rate of
1.5 ml/min. Microdialysates were collected at 2 hr intervals after 2 hr of preper-
fusion. DA, DOPAC, and HVA were analyzed by reverse-phase high-per-
formance liquid chromatography coupled with electrochemical detection.
Detailed procedures are described in the Extended Experimental Procedures.
Electrophysiological Recording
A microdrive array (i.e., hyperdrive) composed of eight to nine tetrodes and
one reference electrode was used for electrophysiological recording in the
VTA of freely moving mice. Neuronal spiking data were amplified and digitized
using a Digital Lynx data acquisition system (Neuralynx). Detailed procedures
are described in the Extended Experimental Procedures.
Cell Culture
Cell culture materials were obtained from Invitrogen. CATH.a cells were
maintained in RPMI1640 supplemented with 4 mM glutamine, 1 mM sodium
pyruvate, 100 U/ml penicillin/streptomycin, and 10% fetal bovine serum.
Transfection and luciferase-reporter assay are described in the Extended
Experimental Procedures.
ChIP Assay
ChIPassayswereperformedusingacommercial assay kit (ThermoFisherScien-
tific) with modifications as described in the Extended Experimental Procedures.866 Cell 157, 858–868, May 8, 2014 ª2014 Elsevier Inc.Statistics
Group differences were evaluated using Student’s t tests or one-way ANOVA
followed by Newman-Keuls comparisons. Locomotion and neuronal firing
rates were evaluated by repeated-measures ANOVA (RM-ANOVA) followed
by Bonferroni tests. Significance was set at p < 0.05.
ACCESSION NUMBERS
The Gene Expression Omnibus (GEO) accession number for the data set pre-
sented in Figure S1 reported in this paper is GSE55119.
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seven figures and can be found with this article online at http://dx.doi.org/
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